25 May 2013
Keywords: first, filing, pioglitazone, takeda, filed, approval, japan
Article | 27 January 1997
Takeda has filed for approval in Japan for Actos (pioglitazonehydrochloride; formerly AD-4833), one of the new products expected to drive ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.